Core Laboratories Inc (CLB) Stock AnalysisCLBStock AnalysisCore Laboratories Inc

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects. It operates in the Industrials sector (OIL & GAS FIELD SERVICES, NEC industry).

Core Laboratories Inc is currently priced at $12.36, which is below the upgraded analyst target of $21, indicating potential upside. However, the recent downgrade by BofA to a target of $11 highlights a significant risk. The RSI is at 58.107, suggesting the stock is nearing overbought territory, and the 20-day price change is +16.17%, indicating recent positive momentum. The main risk is the potential for further declines, as indicated by the 5-day change of -1.28% and the overall YTD change of -27.08%.

18 analysts cover CLB: 10 rate it Buy, 8 Hold and 0 Sell. The average price target is 11.50.